Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates
Abstract Trypanosoma cruzi, the agent of Chagas disease, probably infects tens of millions of people, primarily in Latin America, causing morbidity and mortality. The options